Appointments: Senior Hires At IGM, Cell Medica, Mologen, Navitor, Tenaya, Oncobiologics, Provention Bio And Centrexion

Leading immuno-oncology pioneer, Daniel Chen, has been appointed chief medical officer, a newly created position, at Mountain View, CA-based IGM Biosciences, to lead its clinical development activities. Chen was formerly global head of cancer immunotherapy development at Genentech/Roche. IGM Biosciences, which is evaluating IgM antibodies as therapeutic agents, has also added antibody engineering researcher, William Strohl, to its board of directors.

Cell Medica Ltd., which has offices in London and Houston, has named Chris Nowers as CEO and executive director, following the decision of Gregg Sando to step down. Nowers joins from Kite Pharma, where he was head of Europe, and he previously held senior positions at Avantogen Oncology, Amgen and Bristol-Myers Squibb